Literature DB >> 20478393

SLy2 targets the nuclear SAP30/HDAC1 complex.

Simone Brandt1, Kornelia Ellwanger, Cornelia Beuter-Gunia, Marc Schuster, Angelika Hausser, Ingo Schmitz, Sandra Beer-Hammer.   

Abstract

The adapter protein SLy2 (SH3 protein expressed in lymphocytes 2), also named HACS1, NASH1 or SAMSN1, is expressed in hematopoietic tissues, muscle, heart, brain, lung, pancreas, endothelial cells and myelomas. Endogenous SLy2 expression was shown to be upregulated in primary B cells upon differentiation and proliferation-inducing stimuli, and transduction experiments suggest a stimulatory role for SLy2 in B cell differentiation to plasma cells. However the signalling pathways regulated by SLy2 remain unknown. In this study we identify novel interaction partners of SLy2 providing a molecular framework for its function. We show that phosphorylated SLy2 directly interacts with 14-3-3 proteins via a previously unrecognized phosphorylation site. Furthermore, we demonstrate that 14-3-3 proteins control nucleo-cytoplasmic shuttling of SLy2 by retaining phosphorylated SLy2 in the cytoplasm. In the nucleus, SLy2 interacts with the SAP30/HDAC1 complex and regulates the activity of HDAC1. Thus, our findings unravel a novel mechanism how SLy2 localization is controlled and implicate SLy2 in the epigenetic control of gene expression. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478393     DOI: 10.1016/j.biocel.2010.05.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Immunoinhibitory adapter protein Src homology domain 3 lymphocyte protein 2 (SLy2) regulates actin dynamics and B cell spreading.

Authors:  Max von Holleben; Antje Gohla; Klaus-Peter Janssen; Brian M Iritani; Sandra Beer-Hammer
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

2.  BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.

Authors:  Katja F Krämer; Natalia Moreno; Michael C Frühwald; Kornelius Kerl
Journal:  Int J Mol Sci       Date:  2017-07-16       Impact factor: 5.923

3.  Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.

Authors:  Jiahui Huang; Shumin Zhou; Xin Niu; Bin Hu; Qing Li; Feng Zhang; Xue Zhang; Xiujuan Cai; Yuanlei Lou; Fen Liu; Chenming Xu; Yang Wang
Journal:  Stem Cell Res Ther       Date:  2017-09-19       Impact factor: 6.832

4.  HACS1 signaling adaptor protein recognizes a motif in the paired immunoglobulin receptor B cytoplasmic domain.

Authors:  Jamie J Kwan; Sladjana Slavkovic; Michael Piazza; Dingyan Wang; Thorsten Dieckmann; Philip E Johnson; Xiao-Yan Wen; Logan W Donaldson
Journal:  Commun Biol       Date:  2020-11-13

5.  Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study.

Authors:  Ivyna Bong Pau Ni; Ng Ching Ching; Chang Kian Meng; Zubaidah Zakaria
Journal:  Hematol Rep       Date:  2012-09-28

6.  SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.

Authors:  Yong Yan; Lei Zhang; Tao Xu; Jinxu Zhou; Rong Qin; Chao Chen; Yongxiang Zou; Da Fu; Guohan Hu; Juxiang Chen; Yicheng Lu
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

7.  Characterization of the role of Samsn1 loss in multiple myeloma development.

Authors:  Natasha L Friend; Duncan R Hewett; Vasilios Panagopoulos; Jacqueline E Noll; Kate Vandyke; Krzysztof M Mrozik; Stephen Fitter; Andrew C W Zannettino
Journal:  FASEB Bioadv       Date:  2020-08-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.